FDA Issues Warning Letter to Pinnacle Peptides
December 23, 2025
December 23, 2025
WASHINGTON, Dec. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Pinnacle Professional Research dba Pinnacle Peptides from the Center for Drug Evaluation and Research:
* * *
Recipient: Pinnacle Professional Research dba Pinnacle Peptides, 1001 N Elm Street, Suite 31, Greensboro, NC 27401, United States, service@pinnaclepeptides.com
Issuing Office: Center for Drug Evaluation and Rese . . .
* * *
Recipient: Pinnacle Professional Research dba Pinnacle Peptides, 1001 N Elm Street, Suite 31, Greensboro, NC 27401, United States, service@pinnaclepeptides.com
Issuing Office: Center for Drug Evaluation and Rese . . .